Recognized as Biotech's investment visionary by Scientific American, G. Steven Burrill has authored this informative and respected report that provides an overview of the latest developments and trends in the biotech and life sciences sectors.     This valuable resource is a "must have" for professionals working in and around these industries. As a member of the financial or capital markets, or in commercial operations, business development, investor relations, or a congressional staff member, take the time to learn the facts and data that prepare you for the future.     Biotech 2003 delivers the latest data on the state of the biotech and  the life sciences industries. Arm yourself with this essential 400  page resource. Get the facts behind the news in:    Pharmaceuticals   Diagnostics   Nutraceuticals   Agricultural Biotech   Finance and Capital Markets   Mergers and Acquisitions   Regulatory Agencies   Biodefense    Review qualitative and quantitative analyses of key activities and industry highlights and the prospects for what lies ahead, including:     Technology, product and company developments advancements and setbacks    Legislative bills, regulatory strategies, political agendas, and industry reaction to geopolitical events    Partnering and M&A agreements in the volatile financial market      400 pages of analyses, charts and grafts give the reader a concise and understandable reference to and background on these exciting sectors.

Biotech 2003 Life Sciences: Revaluation and Restructuring

Burrill, G. Steven

Burrill & Company

Biotech 2008 - Life Sciences: A 20 / 20 Vision to 2020 - 22nd Annual Report on the Industry

See the best price to sell, buy or rent books by the Burrill & Company publisher. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Books by Burrill & Company

See the best price to sell, buy or rent books by the Burrill & Company publisher. BookScouter helps to compare book prices from 25+ online bookstores and 30+ buyback vendors with a single search.

Biotech 2003 Life Sciences: Revaluation and Restructuring

Biotech 2008 - Life Sciences: A 20 / 20 Vision to 2020 - 22nd Annual Report on the Industry